FY2023 NIH awards · Principal investigators
Pathology at University of Vermont
Burlington, VT
Funding
$3.2M
$3,158,148
Awards
8
FY2023 NIH awards in Pathology
Principal investigators
5
5 lead a grant here, 0 co-investigators
- NIH names only the principal investigators on an award, so this page lists only them. The department is the award's: it is where ScienceDex counts the award, not a list of the department's members.
- These are the awards in the Pathology row of the University of Vermont page.
Leads a grant in this department
5 contact PIs of these awards, by the funding they lead. Other principal investigators on an award are listed with it and under Co-investigators.
Janssen-Heininger, Yvonne M. W.
Leads 3 awards · $1,945,602
- 5R35HL135828-07Department: NIH department codeS-glutathionylation chemistry in fibrotic lung remodeling$927,588award amount
- 1R01CA273238-01A1Department: NIH department codeGlutaredoxin, Glutathione Metabolism and Lung Cancer$535,116award amount
- 5R01AG074488-02Department: NIH department codeCollagen Oxidation, Myofibroblast Activation and Age-Associated Pulmonary Fibrosis$482,898award amount
Cunniff, Brian
Leads 2 awards · $408,756
- 1R01GM143250-01A1Department: NIH department codeMitochondrial positioning regulates redox-signaling during cell migration$330,756award amount
- 5R03CA270840-02Department: NIH department codeA pilot study to investigate in vivo Miro1 deletion in breast cancer tumorigenesis$78,000award amount
Anathy, Vikas
Leads 1 award · $390,000
- 5R01HL122383-09Department: NIH department codeEndoplasmic Reticulum Stress Signaling in Allergen-induced Airway Remodeling$390,000award amount
Seward, David Joseph
Leads 1 award · $218,790
- 1R21CA280266-01Department: NIH department codeSTK11 loss of function and anti-PD-1 therapy resistance in KRAS-driven lung adenocarcinoma$218,790award amount
Van Der Vliet, Albert
Leads 1 award · $195,000
- 5R21AG075491-02Department: NIH department codeDUOX1 in fibroblast-macrophage cross-talk in pulmonary fibrosis$195,000award amount